Verus Financial Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Verus Financial Partners's LLY Position: Q3 2026 in Review
Verus Financial Partners increased its Eli Lilly (LLY) stake by 4.8% in Q3 2026, buying an estimated $17.7K and bringing the position to 330 shares worth $381K. The position accounts for 0.03% of the portfolio, ranked #98.
Verus Financial Partners first reported a position in LLY in Q3 2020 and has held it in 13 quarters since. The position peaked at $474K in Q2 2024. 4,581 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Verus Financial Partners held 330 shares of Eli Lilly worth $381K as of Q3 2026.
- Verus Financial Partners bought 15 Eli Lilly shares in Q3 2026, an estimated $17.7K.
- Eli Lilly made up 0.03% of Verus Financial Partners's portfolio in Q3 2026, its #98 holding.
- Verus Financial Partners first reported a position in Eli Lilly in Q3 2020 and has held it in 13 quarters since.
- Verus Financial Partners's Eli Lilly position peaked at $474K in Q2 2024.
- 4,581 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Verus Financial Partners's 13F filing for Q3 2026, filed 29 Oct 2026.